{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3130, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "traction", "function": "show_traction", "notes": "Includes waterfall plot for partial response and spider plot for longitudinal tumor change.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/10", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-10", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "2d1a4c73-c8e8-4589-afa1-f1945bbdaa5e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Sizing", "beatSlug": null, "evidence": "The deck provides market sizing information for various indications, including UPS, Osteosarcoma, and metastatic NSCLC.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a process-flow diagram to map patient cohorts to clinical outcomes and subsequent study advancement decisions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/11", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-11", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "2d1a4c73-c8e8-4589-afa1-f1945bbdaa5e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Sizing", "beatSlug": null, "evidence": "The deck provides market sizing information for various indications, including UPS, Osteosarcoma, and metastatic NSCLC.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": "Includes a spider plot for lesion change and a Kaplan-Meier survival curve.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/12", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-12", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "2d1a4c73-c8e8-4589-afa1-f1945bbdaa5e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Sizing", "beatSlug": null, "evidence": "The deck provides market sizing information for various indications, including UPS, Osteosarcoma, and metastatic NSCLC.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "traction", "function": "show_traction", "notes": "Includes Kaplan-Meier survival curve and waterfall plot for lesion change.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/13", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-13", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "2d1a4c73-c8e8-4589-afa1-f1945bbdaa5e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Sizing", "beatSlug": null, "evidence": "The deck provides market sizing information for various indications, including UPS, Osteosarcoma, and metastatic NSCLC.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "traction", "function": "show_traction", "notes": "Clinical trial data showing PFS at 3 months for Liposarcoma and Synovial Sarcoma cohorts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/14", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-14", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "2d1a4c73-c8e8-4589-afa1-f1945bbdaa5e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Sizing", "beatSlug": null, "evidence": "The deck provides market sizing information for various indications, including UPS, Osteosarcoma, and metastatic NSCLC.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "traction", "function": "show_traction", "notes": "Includes specific clinical trial terminology (CTCAE, SAE, RP2D, Q2W).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/15", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-15", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "2d1a4c73-c8e8-4589-afa1-f1945bbdaa5e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Sizing", "beatSlug": null, "evidence": "The deck provides market sizing information for various indications, including UPS, Osteosarcoma, and metastatic NSCLC.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a grid of metrics to establish the total addressable market and clinical benchmarks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/16", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-16", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "2d1a4c73-c8e8-4589-afa1-f1945bbdaa5e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Sizing", "beatSlug": null, "evidence": "The deck provides market sizing information for various indications, including UPS, Osteosarcoma, and metastatic NSCLC.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "traction", "function": "show_traction", "notes": "The chart is a waterfall plot showing maximum change from baseline for different patient cohorts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/17", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-17", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "The slide uses a process-oriented layout to describe clinical trial phases.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/18", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-18", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "traction", "function": "show_traction", "notes": "Clinical trial data for BA3011 in NSCLC patients.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/19", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-19", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "traction", "function": "show_traction", "notes": "Clinical trial data presentation for oncology drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/20", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-20", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "section_divider", "function": "transition", "notes": "The slide serves as a section divider for a deep dive into a specific therapeutic platform.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/21", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-21", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a grid of metrics to define the total addressable market and the specific target segment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/22", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-22", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "traction", "function": "show_traction", "notes": "The chart is a waterfall plot showing percentage change in tumor size for individual patients.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/23", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-23", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a 2x2 grid of metrics to frame the market problem, followed by specific target population and success threshold data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/24", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-24", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "traction", "function": "show_traction", "notes": "The chart displays longitudinal data for two specific patients, showing sustained complete response.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/25", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-25", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "market_sizing", "function": "size_opportunity", "notes": "SCCHN = Squamous Cell Carcinoma of the Head and Neck. ROR2 is the target biomarker.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/26", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-26", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a table to present clinical outcomes for specific tumor types, emphasizing the first-in-class potential of the therapy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/27", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-27", "loopMatches": [ { "to": 27, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "70b35119-d82b-4aab-a655-ee1318f5401a", "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating potential for quick wins and big bets.", "position": 2, "objective": "What are the potential quick wins and big bets for BioAtla's CAB technology?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 27, "from": 10, "beatId": "c5004055-d5ec-4e67-8d3c-a6006b26dc07", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck presents encouraging Phase 1 and 2 results for various indications, demonstrating traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a process-oriented layout to describe clinical trial phases.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/28", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/29", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a combination of a comparison table for clinical data and a dot plot for NHP toxicity data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/30", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a timeline-based visual to show dose escalation steps leading to RP2D selection.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/31", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/32", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "traction", "function": "show_traction", "notes": "The chart shows tumor volume over time for three different antibody treatments, with the CAB-EpCAM x CAB-CD3 showing the best efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/33", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a timeline-based table structure to map programs to specific clinical milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/34", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-34", "loopMatches": [ { "to": 34, "from": 34, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "03ba9e29-4737-4781-bf23-7a104eec0cd6", "evidence": "The deck mentions key upcoming milestones in 2022, indicating that now is a critical time for the company's technology.", "position": 1, "objective": "Why is now the right time for BioAtla's CAB technology?", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.6, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "executive_summary", "function": "summarize", "notes": "Uses a linked-circle diagram to represent interconnected business pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/35", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/36", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-36", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-42e0-708e-bbdb-4616fa343de3", "docSlug": "252a92bcbab8bda657ee7494bf765251", "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/37", "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3", "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/LlTjKyqNJ9RgTW_Fo_486xXg5Z97sDX8Cwg5GfKL91Q/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mZDMxNmVhODAxZmYxMzE4NjUzNzkyMmZkOGQ2YjZiMi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/1", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/lUDbhfdRLoRCzT3MEZdazZkdVAjvPsR5kX9Ci__qzhU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mZDMxNmVhODAxZmYxMzE4NjUzNzkyMmZkOGQ2YjZiMi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/QcHlvgmwyAbnCXGt92zC9fqeijj7EJCwSeQFrxenIAY/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mZDMxNmVhODAxZmYxMzE4NjUzNzkyMmZkOGQ2YjZiMi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/lhPQHlFScrIbIe1cmwoeJ7Yf3SK_TdjYycUJcathb7Q/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mZDMxNmVhODAxZmYxMzE4NjUzNzkyMmZkOGQ2YjZiMi9wMDAxLnBuZw" }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/2", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "appendix_disclosure", "function": "other", "notes": "Standard pharmaceutical regulatory disclosure slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/3", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "appendix_disclosure", "function": "other", "notes": "Standard pharmaceutical regulatory disclosure slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/4", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "appendix_disclosure", "function": "other", "notes": "Standard pharmaceutical safety disclosure slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/5", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "vision", "function": "inspire_vision", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/6", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-6", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "a95c68d2-4f0e-4712-bb5a-1c11ebd137eb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "OUR VISION and BioNTech Today slides set up the problem and context", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a semi-circular layout to represent the company's strategic pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/7", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-7", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "a95c68d2-4f0e-4712-bb5a-1c11ebd137eb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "OUR VISION and BioNTech Today slides set up the problem and context", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a structured grid layout to categorize key performance indicators.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/8", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-8", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a list-based timeline/milestone format to highlight growth across five key areas.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/9", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-9", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "other", "function": "other", "notes": "The slide highlights organizational scale and diversity metrics as of Dec 31, 2021.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/10", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-10", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "other", "function": "other", "notes": "The slide uses a structured layout to present four pillars of corporate social responsibility.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/11", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-11", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "customer_logos", "function": "cite_precedent", "notes": "The slide categorizes partnerships into clinical stage and pre-clinical programs, detailing the nature of the collaboration (e.g., cost/profit share, royalties).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/12", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-12", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/13", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-13", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 14, "from": 13, "beatId": "c8c832ec-37ff-436d-a52a-73af2b588e37", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "MULTI-PLATFORM STRATEGY and Multi-platform Strategy: Toolbox for Innovation slides present the solution", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "solution", "function": "present_solution", "notes": "The diagram uses a hexagonal grid to represent different technology platforms and their development status/origin.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/14", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-14", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 14, "from": 13, "beatId": "c8c832ec-37ff-436d-a52a-73af2b588e37", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "MULTI-PLATFORM STRATEGY and Multi-platform Strategy: Toolbox for Innovation slides present the solution", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/15", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-15", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "roadmap", "function": "plan_implementation", "notes": "Uses a temporal progression layout (Today -> Mid-term -> Long-term).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/16", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-16", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" }, { "to": 18, "from": 16, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "671ac4be-c8c9-4cb3-9105-216241bf1aac", "evidence": "Emphasis on once-in-a-generation opportunity", "position": 1, "objective": "The cost of not investing in BioNTech's technology", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 18, "from": 16, "beatId": "bd059346-7b66-497b-b62e-1251cef531c4", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "roadmap slides show market potential and progress", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "traction", "function": "show_traction", "notes": "Includes product image and key performance metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/17", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-17", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" }, { "to": 18, "from": 16, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "671ac4be-c8c9-4cb3-9105-216241bf1aac", "evidence": "Emphasis on once-in-a-generation opportunity", "position": 1, "objective": "The cost of not investing in BioNTech's technology", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 18, "from": 16, "beatId": "bd059346-7b66-497b-b62e-1251cef531c4", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "roadmap slides show market potential and progress", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "traction", "function": "show_traction", "notes": "Slide highlights both historical traction (>3.6bn doses) and future growth vectors (label expansion, boosters, next-gen vaccines).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/18", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-18", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" }, { "to": 18, "from": 16, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "671ac4be-c8c9-4cb3-9105-216241bf1aac", "evidence": "Emphasis on once-in-a-generation opportunity", "position": 1, "objective": "The cost of not investing in BioNTech's technology", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 18, "from": 16, "beatId": "bd059346-7b66-497b-b62e-1251cef531c4", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "roadmap slides show market potential and progress", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a two-column layout to contrast the 'why' (medical need) with the 'how' (technologies).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/19", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-19", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 24, "from": 19, "beatId": "24f1c7cb-ed51-471a-8d42-de7584f2b8af", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Infectious Diseases and Oncology slides showcase product pipeline", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "roadmap", "function": "plan_implementation", "notes": "The chart uses a horizontal bar representation to indicate the clinical stage of each program.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/20", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-20", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 24, "from": 19, "beatId": "24f1c7cb-ed51-471a-8d42-de7584f2b8af", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Infectious Diseases and Oncology slides showcase product pipeline", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "solution", "function": "present_solution", "notes": "The diagram illustrates a circular, iterative process (flywheel) connecting patient samples and variability to specific drug classes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/21", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-21", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 24, "from": 19, "beatId": "24f1c7cb-ed51-471a-8d42-de7584f2b8af", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Infectious Diseases and Oncology slides showcase product pipeline", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a hub-and-spoke diagram to show how various modalities converge on patient care.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/22", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-22", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 24, "from": 19, "beatId": "24f1c7cb-ed51-471a-8d42-de7584f2b8af", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Infectious Diseases and Oncology slides showcase product pipeline", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "roadmap", "function": "show_traction", "notes": "The slide uses a Gantt-style visualization to show clinical trial phases for various drug candidates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/23", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-23", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 24, "from": 19, "beatId": "24f1c7cb-ed51-471a-8d42-de7584f2b8af", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Infectious Diseases and Oncology slides showcase product pipeline", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "product_demo", "function": "present_solution", "notes": "The slide uses a matrix structure to compare different drug development programs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/24", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-24", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 24, "from": 19, "beatId": "24f1c7cb-ed51-471a-8d42-de7584f2b8af", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Infectious Diseases and Oncology slides showcase product pipeline", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/25", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-25", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 27, "from": 25, "beatId": "dcebfaba-d432-46da-9da5-13b603bd7ad6", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "The Ask", "beatSlug": "sequoia-pitch-the-ask", "evidence": "OUTLOOK 2022 and 2022 Strategic Priorities slides outline ask", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a grouped table structure to categorize milestones by therapeutic area (COVID-19, Infectious Disease, Oncology, Data Updates).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/26", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-26", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 27, "from": 25, "beatId": "dcebfaba-d432-46da-9da5-13b603bd7ad6", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "The Ask", "beatSlug": "sequoia-pitch-the-ask", "evidence": "OUTLOOK 2022 and 2022 Strategic Priorities slides outline ask", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "key_messages", "function": "plan_implementation", "notes": "The slide uses a column-based layout to categorize strategic initiatives, with a footer highlighting foundational enablers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/27", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-27", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 27, "from": 25, "beatId": "dcebfaba-d432-46da-9da5-13b603bd7ad6", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "The Ask", "beatSlug": "sequoia-pitch-the-ask", "evidence": "OUTLOOK 2022 and 2022 Strategic Priorities slides outline ask", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4386-7700-b700-92166fcbcd7c", "docSlug": "fd316ea801ff13186537922fd8d6b6b2", "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "appendix", "function": "front_matter", "notes": "This is a standard corporate contact/footer slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/28", "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c", "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-28", "loopMatches": [ { "to": 28, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976", "evidence": "The presentation follows a 'why-what-how' structure", "position": 0, "objective": "Why BioNTech's approach is necessary and beneficial", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4472-76ed-a8f3-3d6ae669b88a", "docSlug": "6078678dfcf31020360c86ce90f559c0", "documentTitle": "BioNTech | Results Presentation Deck | 32 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/SUi49TvfB6Pxh6FSW3P7eSHqw_jK73LGeSeXVte8aIw/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82MDc4Njc4ZGZjZjMxMDIwMzYwYzg2Y2U5MGY1NTljMC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4472-76ed-a8f3-3d6ae669b88a/1", "deckHref": "/decks/019de073-4472-76ed-a8f3-3d6ae669b88a", "deckAnchorHref": "/decks/019de073-4472-76ed-a8f3-3d6ae669b88a#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/M4Xtd-3pK96t8rIh0egR_ZZtZrIuYu7v7aUs-DdydiQ/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82MDc4Njc4ZGZjZjMxMDIwMzYwYzg2Y2U5MGY1NTljMC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/tfOQKLyZnX39kU_0N3PQElb-I0W5_FcjI_4yPK3iUzY/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82MDc4Njc4ZGZjZjMxMDIwMzYwYzg2Y2U5MGY1NTljMC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/07vM5XoS7FlyickDrh_IrURPUsA0U0lIQlPjeFFEmJM/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82MDc4Njc4ZGZjZjMxMDIwMzYwYzg2Y2U5MGY1NTljMC9wMDAxLnBuZw" }, { "docId": "019de073-4472-76ed-a8f3-3d6ae669b88a", "docSlug": "6078678dfcf31020360c86ce90f559c0", "documentTitle": "BioNTech | Results Presentation Deck | 32 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4472-76ed-a8f3-3d6ae669b88a/2", "deckHref": "/decks/019de073-4472-76ed-a8f3-3d6ae669b88a", "deckAnchorHref": "/decks/019de073-4472-76ed-a8f3-3d6ae669b88a#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4472-76ed-a8f3-3d6ae669b88a", "docSlug": "6078678dfcf31020360c86ce90f559c0", "documentTitle": "BioNTech | Results Presentation Deck | 32 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "disclaimer", "function": "other", "notes": "This is a standard pharmaceutical regulatory disclosure slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4472-76ed-a8f3-3d6ae669b88a/3", "deckHref": "/decks/019de073-4472-76ed-a8f3-3d6ae669b88a", "deckAnchorHref": "/decks/019de073-4472-76ed-a8f3-3d6ae669b88a#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-4472-76ed-a8f3-3d6ae669b88a", "docSlug": "6078678dfcf31020360c86ce90f559c0", "documentTitle": "BioNTech | Results Presentation Deck | 32 slides", "authorId": "biontech", "authorName": "BioNTech", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "disclaimer", "function": "other", "notes": "Standard pharmaceutical regulatory disclosure slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-4472-76ed-a8f3-3d6ae669b88a/4", "deckHref": "/decks/019de073-4472-76ed-a8f3-3d6ae669b88a", "deckAnchorHref": "/decks/019de073-4472-76ed-a8f3-3d6ae669b88a#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }